Fourpath Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.84M | Sell |
9,477
-142
| -1% | -$57.6K | 0.6% | 45 |
|
|
2025
Q1 | $4.79M | Sell |
9,619
-114
| -1% | -$56.7K | 0.83% | 32 |
|
|
2024
Q4 | $5.06M | Sell |
9,733
-207
| -2% | -$108K | 0.94% | 33 |
|
|
2024
Q3 | $6.15M | Buy |
9,940
+9,435
| +1,868% | +$5.84M | 1.13% | 24 |
|
|
2024
Q2 | $279K | Sell |
505
-29
| -5% | -$16K | 0.21% | 100 |
|
|
2024
Q1 | $310K | Sell |
534
-3
| -0.6% | -$1.74K | 0.22% | 92 |
|
|
2023
Q4 | $285K | Buy |
537
+72
| +15% | +$38.2K | 0.19% | 96 |
|
|
2023
Q3 | $235K | Buy |
465
+52
| +13% | +$26.3K | 0.18% | 104 |
|
|
2023
Q2 | $215K | Sell |
413
-23
| -5% | -$12K | 0.26% | 91 |
|
|
2023
Q1 | $251K | Sell |
436
-45
| -9% | -$25.9K | 0.18% | 107 |
|
|
2022
Q4 | $265K | Sell |
481
-70
| -13% | -$38.5K | 0.19% | 103 |
|
|
2022
Q3 | $279K | Sell |
551
-80
| -13% | -$40.5K | 0.19% | 99 |
|
|
2022
Q2 | $343K | Sell |
631
-28
| -4% | -$15.2K | 0.21% | 97 |
|
|
2022
Q1 | $389K | Sell |
659
-48
| -7% | -$28.3K | 0.15% | 109 |
|
|
2021
Q4 | $472K | Buy |
+707
| New | +$472K | 0.18% | 95 |
|